Literature DB >> 3962637

Radical synovectomy with muscle release for the rheumatoid elbow.

T Saito, T Koshino, R Okamoto, S Horiuchi.   

Abstract

Twenty-three synovectomies of the elbow with concomitant muscle release at the humeral epicondyles were performed in 21 patients with rheumatoid arthritis. Ten elbows were classified as anatomical Stage 2, 12 as Stage 3, and one as Stage 4. The patients were followed from 1 to 8 years. Postoperative clinical results showed improved relief of pain, and range of motion, and activities of daily living. Increased range of motion with improvement of flexion contracture was obtained in most cases by releasing the muscle insertions around the humeral epicondyles and by resecting the radial head and bony spurs of the coronoid and the olecranon. The operation was beneficial even at advanced stages.

Entities:  

Mesh:

Year:  1986        PMID: 3962637     DOI: 10.3109/17453678608993220

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  5 in total

1.  Results of elbow synovectomy in rheumatoid arthritis.

Authors:  V Vahvanen; A Eskola; J Peltonen
Journal:  Arch Orthop Trauma Surg       Date:  1991       Impact factor: 3.067

Review 2.  Rheumatoid synovectomy: does the surgical approach matter?

Authors:  Peter N Chalmers; Seth L Sherman; Bradley S Raphael; Edwin P Su
Journal:  Clin Orthop Relat Res       Date:  2011-01-07       Impact factor: 4.176

Review 3.  NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets.

Authors:  Yixuan Zhang; Priya Murugesan; Kai Huang; Hua Cai
Journal:  Nat Rev Cardiol       Date:  2019-10-07       Impact factor: 32.419

Review 4.  [Minimally invasive therapy of rheumatoid cubarthritis].

Authors:  K Schmidt
Journal:  Z Rheumatol       Date:  2008-10       Impact factor: 1.372

5.  Good long-term outcome of synovectomy in advanced stages of the rheumatoid elbow.

Authors:  Katsushi Ishii; Yutaka Inaba; Yuichi Mochida; Tomoyuki Saito
Journal:  Acta Orthop       Date:  2012-08-10       Impact factor: 3.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.